Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Fund House: Tata Mutual Fund| Category: Equity: Sectoral-Pharma and Healthcare |
| Launch Date: 28-12-2015 |
| Asset Class: Equity |
| Benchmark: NIFTY Pharma TRI |
| TER: 2.15% As on (30-03-2026) |
| Status: Open Ended Schemes |
| Minimum Investment: 5000.0 |
| Minimum Topup: 1000.0 |
| Total Assets: 1,228.79 Cr As on 31-03-2026(Source:AMFI) |
| Turn over: 22.57% | Exit Load: 0.25% of NAV if redeemed /switched out before 30 days from the date of allotment. |
29.4072
0.07 (0.2251%)
11.0%
Benchmark: 14.09%
PERFORMANCE
Fund Multiplier
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
Investment Objective
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
Current Asset Allocation (%)
Indicators
| Standard Deviation | 16.87 |
| Sharpe Ratio | 0.8 |
| Alpha | -1.04 |
| Beta | 0.96 |
| Yield to Maturity | - |
| Average Maturity | - |
PEER COMPARISON
Scheme Characteristics
Minimum investment in equity & equity related instruments of a particular sector/ particular theme - 80% of total assets.
Riskometer
PORTFOLIO
Market Cap Distribution
Small Cap
38.64%
Others
2.44%
Large Cap
42.52%
Mid Cap
16.4%
